Day One Biopharmaceuticals Inc (DAWN) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Day One Biopharmaceuticals Inc   (NASDAQ: DAWN)
 

Day One Biopharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DAWN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 83.92 % 7.99 % 8.07 % 9.17 %
Q / Q Revenue Growth (Q4 MRQ) 34.99 % 1.44 % 1.81 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 20.6 % 7.45 % 6.99 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) 18.34 % 4.21 % 3.47 % 2.08 %
Revenue 5 Year Average Growth - 8.75 % 9.34 % 10.71 %


DAWN's Growth Comparisons in IV. Quarter 2025




Day One Biopharmaceuticals Inc showed respectable 83.92% year on year rise of Revenue in the fourth quarter 2025, comparing favorably to the 7.99% growth in the Major Pharmaceutical Preparations industry, and 8.07% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Major Pharmaceutical Preparations industry, Day One Biopharmaceuticals Inc reported above average market Sales growth.

Company's sequential top-line increase was 34.99% from the third quarter. Average annual sales rise for Day One Biopharmaceuticals Inc is %, while S & P 500's average yearly sales growth is 10.71% over the five years, including only Businesses with the fourth quarter 2025 Results.

DAWN Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Total
-57.56 %
17.36 %


Growth Rates of DAWN's Income in the fourth quarter 2025


DAWN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 53.67 % 27.58 % 29.95 %
Sequential Operating Income Change (Q4 MRQ) - -27.23 % -17.34 % 4.5 %
Y / Y Operating Income Growth (Q4 TTM) - 47.82 % 36.91 % 14.37 %
Sequential Operating Income Growth (Q4 TTM) - 13.43 % 9.69 % 6.96 %
Operating Income 5 Year Avg. Change - 14.98 % 10.62 % 19.3 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - - - 21.83 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - - - 11.13 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - -58.66 % -24.72 % 16.46 %
Sequential Income from Cont. Ops. Change (Q4 TTM) - -8.45 % -5.86 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change - 14.8 % 8.95 % -28.62 %

DAWN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - -26.31 % 16.68 % 21.56 %
Q / Q Net Income Growth (Q4 MRQ) - -43.39 % -34.6 % 11.12 %
Y / Y Net Income Change (Q4 TTM) - 27.39 % 32.85 % 16.59 %
Sequential Net Income Change (Q4 TTM) - 3.49 % 7.36 % 6.03 %
Net Income 5 Year Avg. Growth - 14.99 % 9.41 % 23.12 %

DAWN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - - - 21.83 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - - - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth - 2.01 % 8.95 % -28.62 %



DAWN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - -29.55 % 16.68 % -28.62 %
Q / Q EPS Net Growth (Q4 MRQ) - -32.42 % -34.6 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - -99.87 %
EPS Net 5 Year Avg. Change - 14.99 % 9.41 % 23.12 %



Day One Biopharmaceuticals Inc reported bottom-line of $ -1,039.05 in the fourth quarter, compare to $ -1,023.94 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -29.55%, while Healthcare sector increased by 16.68%, and overall market improved by 21.56%.

The company's sequential bottom-line increase was 34.99% from the third quarter. Average annual income per share rise for Day One Biopharmaceuticals Inc is %, while S & P 500's average yearly income per share growth is 23.12% over the five years, including only Businesses with the fourth quarter 2025 earnings results.

DAWN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - -15.03 % -10.42 % 2 %
Sequential Free Cash Flow Change (Q4 MRQ) - -44.17 % -28.82 % 22.32 %
Y / Y Free Cash Flow Change (Q4 TTM) - 9.77 % 10.95 % 11.81 %
Sequential Free Cash Flow Change (Q4 TTM) - 1.86 % 1.77 % 2.41 %
Free Cash Flow 5 Year Avg. Change - 4.86 % 2.66 % 12.12 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - -90.24 % 1035.72 %
Sequential Net Cash Flow Change (Q4 MRQ) 1909.16 % - -99.01 % -
Y / Y Net Cash Flow Change (Q4 TTM) - -25.37 % -25.5 % -
Sequential Net Cash Flow Change (Q4 TTM) - -46.98 % -27.24 % -
Net Cash Flow 5 Year Avg. Change - 29.88 % 6.46 % 1.12 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) - 19.29 % 9.45 % 23.41 %
Sequential Capital Expenditures Change (Q4 MRQ) - 20.61 % 18.78 % 18.97 %
Y / Y Capital Expenditures Change (Q4 TTM) -80.18 % 21.38 % 11.09 % 23.88 %
Sequential Capital Expenditures Change (Q4 TTM) -27.09 % 12.06 % 6.99 % 7.02 %
Capital Expenditures 5 Year Avg. Change - 7.66 % 8.45 % 13.27 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.